Drug, insurance companies oppose public insurance
As the health care debate heats up in Washington, insurance and drug companies are keeping their lobbyists busy. So far this year, those industries have increased their lobbyist spending by 41% as they fight a proposed public insurance plan, USA Today
reports. That's $35 million in the first quarter for...